Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Reviews15 April 2003Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor ProgressionDaniel J. Brat, MD, PhD and Timothy B. Mapstone, MDDaniel J. Brat, MD, PhDFrom Emory University School of Medicine, Atlanta, Georgia. and Timothy B. Mapstone, MDFrom Emory University School of Medicine, Atlanta, Georgia.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-138-8-200304150-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Clinical PrinciplesMalignant gliomas occur primarily in patients 40 to 70 years of age.Clinical presentation depends on tumor location and can include headache, seizures, or mental status changes.Age, functional status at presentation, and seizures are important predictors of outcome.Therapeutic options include aggressive surgery, but since resection alone is not often curative, adjunctive therapy is warranted.Patients with glioblastoma multiforme have a median survival of 50 weeks.Pathophysiologic PrinciplesMicrovascular proliferation in glioblastoma multiforme is a form of angiogenesis associated with neoplastic progression.Vascular proliferation is often noted in hypoxic regions associated with necrosis and is due at least in part to hypoxia-inducible factormediated expression of ...References1. Cavenee WK, Furnari FB, Nagane M, Huang HJ, Newcombe EW, Bigner DD, . Diffusely infiltrating astrocytomas.. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Lyon: International Agency for Research; 2000:10-21. Google Scholar2. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and Its Coverings. 4th ed. New York: Churchill Livingstone; 2002. Google Scholar3. Statistical Report: Primary Brain Tumors in the United States, 19921997. Chicago: Central Brain Tumor Registry of the United States; 2000. Google Scholar4. Bernstein M, Berger MS. Neuro-Oncology: The Essentials. New York: Thieme Medical Publishers; 2001. Google Scholar5. Folkman J. What is the evidence that tumors are angiogenesis dependent? [Editorial]. J Natl Cancer Inst. 1990;82:4-6. [PMID: 1688381] CrossrefMedlineGoogle Scholar6. Brat DJ, Castellano-Sanchez A, Kaur B, Van Meir EG. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol. 2002;9:24-36. [PMID: 11756757] CrossrefMedlineGoogle Scholar7. Brat DJ, Van Meir EG. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am J Pathol. 2001;158:789-96. [PMID: 11238026] CrossrefMedlineGoogle Scholar8. Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol. 1995;54:304-10. [PMID: 7745429] CrossrefMedlineGoogle Scholar9. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-57. [PMID: 11001068] CrossrefMedlineGoogle Scholar10. Dvorak HF. VPF/VEGF and the angiogenic response. Semin Perinatol. 2000;24:75-8. [PMID: 10709865] CrossrefMedlineGoogle Scholar11. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-5. [PMID: 6823562] CrossrefMedlineGoogle Scholar12. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-64. [PMID: 8756718] CrossrefMedlineGoogle Scholar13. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-8. [PMID: 1279432] CrossrefMedlineGoogle Scholar14. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-5. [PMID: 1279431] CrossrefMedlineGoogle Scholar15. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7:345-50. [PMID: 11516994] CrossrefMedlineGoogle Scholar16. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001;11:293-9. [PMID: 11377966] CrossrefMedlineGoogle Scholar17. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, . Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 1996;56:2185-90. [PMID: 8616870] MedlineGoogle Scholar18. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer. 2000;88:2606-18. [PMID: 10861440] CrossrefMedlineGoogle Scholar19. Wang GL, Jiang BH, Rue EA, Se
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Recent studies have shown that ubiquitination by VHL occurs only after the oxygen-dependent hydroxylation of a key proline of HIF-1 ( 24 ).”
BackgroundCell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774 · cited 1×
“They are activated by extracellular ligand binding and undergo autophosphorylation on key tyrosine residues (31).”
BackgroundHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“Hypoxia-inducible factor-1 protein is normally maintained at low levels through a continuous degradation process dependent on ubiquitination of the protein (the enzymatic addition of ubiquitin, which marks the protein for destruction) followed by proteasomal degradation (the ubiquitin-dependent proteasome pathway) ( 2…”
BackgroundAsparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · cited 1×
“Conversely, this physical interaction diminishes the transcriptional activity of HIF-1 by causing decreased protein levels of HIF-1 (48).”
BackgroundHypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Cited by
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
Rong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Self-citationXia, X., Lemieux, M. E., Li, W., Carroll, J. S., Brown, M., Liu, X. S., & Kung, A. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810067106 · Cited by 410
Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Hwang, W.-T., Nelson, P. T., Lustig, R. A., Jenkins, K., Magarelli, D. P., Hahn, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1081 · Cited by 356
Qian, M., Wang, S., Guo, X., Wang, J., Zhang, Z., Qiu, W., Gao, X., Chen, Z., Xu, J., Zhao, R., et al. (2020) · Oncogene · doi:10.1038/s41388-019-0996-y · Cited by 345
Metadata
- Authors
- Brat, D. J., & Mapstone, T. B.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2003-04-15
- Volume
- 138
- Issue
- 8
- Pages
- 659-668
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1976860925
- Cited by
- 111
- References
- 11
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression. https://app.cochat.ai/papers/10.7326/0003-4819-138-8-200304150-00014
- The paper
- Brat, D. J., & Mapstone, T. B. (2003). Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-138-8-200304150-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.